Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and Parkinsonian Disorders

3,4-dihydroxyphenylacetaldehyde has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cooney, A; Goldstein, DS; Gross, DJ; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P; Sullivan, R1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylacetaldehyde and Parkinsonian Disorders

ArticleYear
Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.
    Journal of neurochemistry, 2012, Volume: 123, Issue:6

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cytoplasmic Vesicles; Dopamine; Neurons; Parkinsonian Disorders; PC12 Cells; Rats

2012